[Abnormal WT1 gene expression in paroxysmal nocturnal hemoglobinuria]

Area of Science:

• Hematology
• Molecular Biology
• Oncology

Context:

• Paroxysmal nocturnal hemoglobinuria (PNH) is a rare acquired blood disorder characterized by complement-mediated hemolysis.
• The role of Wilms tumor 1 (WT1) gene expression in PNH pathogenesis remains incompletely understood.

Purpose:

• To investigate the role of WT1 gene expression in the pathogenesis of PNH.
• To explore the effect of WT1 gene silencing on PNH clone characteristics.

Summary:

• WT1 mRNA expression was significantly higher in CD59-negative bone marrow mononuclear cells (BMMNC) from PNH patients compared to CD59-positive PNH BMMNC and normal BMMNC.
• WT1 expression positively correlated with the proportion of CD59-negative cells in PNH patients.
• Silencing WT1 using small interfering RNA (siRNA) in PNH CD59-negative BMMNC reduced WT1 expression, inhibited cell proliferation (altered cell cycle distribution), and increased apoptosis.

Impact:

• WT1 gene expression may contribute to PNH clone proliferation.
• Targeting WT1 could be a potential therapeutic strategy for PNH by inhibiting clone expansion and promoting cell death.